Experience Unmatched Absorption with Liposomal NAD+: A Game Changer for Health

NAD+: The Cornerstone of Cellular Health and Longevity

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme critical for energy production, DNA repair, and gene regulation. It plays a crucial role in:

✔ Energy production – powering mitochondria to generate ATP (cellular energy).

✔ DNA repair – maintaining genetic integrity and reducing cellular aging.

✔ Metabolism regulation – supporting fat oxidation and glucose metabolism.

✔ Brain function – enhancing cognitive clarity and neurological health.

However, NAD+ levels decline significantly with age—nearly 50% by middle age^[1]. This decline is associated with fatigue, cognitive decline, and increased risk of chronic diseases like diabetes and neurodegenerative disorders. Restoring NAD+ levels has become a key strategy in anti-aging science, but not all NAD+ supplements are equally effective.

Why Traditional NAD+ Supplements Fail to Deliver

While the market offers various NAD+ supplements—including NADH, NR (Nicotinamide Riboside)—they come with three critical challenges:

1. Poor Absorption: NAD+’s large molecular weight (663.4 g/mol) and complex structure prevent efficient absorption in the intestinal tract and cellular uptake ^[2], reducing the effectiveness of oral supplements.
2. Rapid Degradation: Unprotected NAD+/NADH is highly susceptible to breakdown in the digestive tract, losing most of its potency before reaching cells, resulting in a short shelf life ^[2].
3. Precursor Limitations: While NR can serve as a precursor to boost NAD+ levels, its effectiveness varies across different tissues ^[3].

Due to these limitations, liposomal technology has emerged as the superior solution for maximizing NAD+ absorption and efficacy.

Liposomal Technology: The Breakthrough in Bioavailability

Liposomal NAD+ is a scientific supplement formulation breakthrough, solves absorption and stability issues. Using LipoAvail™ Liposomal Technology, active NAD+ molecules are encapsulated within liposomes—microscopic, phospholipid-based spheres that protect and transport nutrients directly into cells.

How Liposomal Technology Solves Traditional Shortcomings:

1. Enhanced Absorption and Stability

· 9X Higher Bioavailability: Our study shows that LipoAvail™ NAD+ demonstrates 9 times greater NAD+ concentration in the liver compared to standard supplements, ensuring maximal cellular impact.

· Stomach Acid Resistance: By encapsulating active ingredients, liposomes prevent degradation by digestive enzymes and acids, ensuring effective delivery to the bloodstream.

2. Multi-Tissue Efficacy

Liposomal NAD+ is designed for enhanced absorption, potentially supporting cognitive health and metabolic function by improving cellular NAD+ availability^[2].

3.LipoAvail™’s 360° Quality Assurance

EffePharm’s proprietary 360° Multi-Dimensional Quality Evaluation System ensures:

· Optimal nanoparticle size (less than 100nm) for cellular uptake.

· Encapsulation efficiency up to 85%.

· Stability under varying temperatures, validated via electron microscopy.

This rigorous approach guarantees consistent, high-performance formulations—a key differentiator for brands prioritizing efficacy.

Conclusion: Elevate Your Brand with Next-Gen NAD+

For businesses targeting educated consumers and clinicians, LipoAvail™ Liposomal NAD+ offers more than a product—it is an innovation partnership. With unmatched absorption, multi-tissue delivery, and peer-reviewed results, this technology positions brands as leaders in the $23 billion anti-aging market.

Experience the best NAD+ supplement today—powered by cutting-edge LipoAvail™ technology.

References

1.Shin-ichiro Imai, Leonard Guarente. (2014). NAD+ and Sirtuins in Aging and Disease. Trends Cell Biol. 2014 Aug;24(8):464-71. doi: 10.1016/j.tcb.2014.04.002. Epub 2014 Apr 29.

2.Samuel A J Trammell, Benjamin J Weidemann et al. (2016). Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Sci Rep. 2016 May 27:6:26933. doi: 10.1038/srep26933.

3.Freeberg, K. A., Udovich, C. C., Martens, C. R., Seals, D. R., & Craighead, D. H. (2023). Dietary supplementation with NAD⁺-boosting compounds in humans: Current knowledge and future directions. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 78(12), 2435–2448. https://doi.org/10.1093/gerona/glad106